NIH-funded research Fellowship grant

Understanding how a specific protein from orthopoxvirus affects immune response

Official title: Uncovering the molecular underpinnings of C15, a potent orthopoxvirus virulence factor

Funded at University of Pennsylvania · NIH-10900539 · Data updated 2026-11-12

This study is looking at a protein from a virus that can help it avoid the immune system, and by understanding how this protein works with certain immune cells, we hope to find new ways to treat infections caused by this virus.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 1, 2024
Project endJuly 31, 2025
Funding year2024
Award (this year)$36,803
NIH project number1F31AI183694-01
Project IDNIH-10900539 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of orthopoxvirus infections, including those with compromised immune systems or those living in areas experiencing outbreaks.

Less likely to help

Patients who are not at risk for orthopoxvirus infections or those who have already been vaccinated may not benefit from this research.

What this research studies

This research investigates the role of the C15 protein from orthopoxvirus, which is known to inhibit immune responses in infected individuals. By studying how C15 interacts with immune cells, particularly CD8 T cells and natural killer cells, the research aims to uncover the molecular mechanisms that contribute to the virus's ability to cause disease. The approach involves detailed biological assays and analysis of the protein's structure and function, which could lead to new strategies for treating infections caused by orthopoxviruses.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective treatments and vaccines against orthopoxvirus infections.

How similar studies have gone: Previous research has shown promise in understanding viral proteins and their interactions with the immune system, indicating that this approach could yield valuable insights.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Carro, Stephen David — University of Pennsylvania
  • Study coordinator: Carro, Stephen David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.